FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
BMC cardiovascular disorders2017; 17(1); 289; doi: 10.1186/s12872-017-0720-1

Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation.

Abstract: Atrial fibrillatory cycle length has been considered one of the indices of atrial electrical remodelling during atrial fibrillation (AF), which can be assessed from surface ECG by computer-assisted calculation of atrial fibrillatory rate (AFR). Horses have been suggested as a bona fide model for AF studies since horses too, develop lone AF, however data on AF characteristics in horses are extremely sparse and non-invasive characterization of AF complexity using surface ECG processing has not been reported. Objective: The aim was to study characteristics of induced AF and its modification by flecainide. Methods: The study group consisted on 3 horses with spontaneous persistent AF and 13 with pace-induced AF. Seven horses were treated with saline (control) and eight with flecainide (2 mg/kg). ECGs were analysed using spatiotemporal cancellation of QRST complexes and calculation of AFR from the residual atrial signal. Results: At AF onset, AFR was 295 ± 52 fibrillations per minute (fpm) in the horses with induced AF treated with flecainide, 269 ± 36 fpm in the control group (ns), and 364 ± 26 fpm in the horses with spontaneous persistent AF (P < 0.05 compared to the control group). Flecainide caused a decrease in AFR in all animals and restored sinus rhythm in the animals with induced AF. In the control animals, AFR increased from 269 ± 36 fpm to a plateau of 313 ± 14 fpm before decreasing to 288 ± 28 fpm during the last 10% of the AF episodes preceding spontaneous conversion (P < 0.05). Conclusions: AFR in horses with induced AF resembles AFR in humans with paroxysmal AF. Flecainide caused a rapid decrease in AFR in all horses, further supporting the method to be a non-invasive technique to study the effect of antiarrhythmic compounds.
Get Full Text
Publication Date: 2017-12-08 PubMed ID: 29221440PubMed Central: PMC5723027DOI: 10.1186/s12872-017-0720-1Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explores the impacts of a drug called flecainide on atrial fibrillatory rate (AFR) in horses. The study used horses because their hearts develop a condition called atrial fibrillation (AF) just like in humans, but up until now, there’s been limited data on this disease in horses.

Objective and Methods

The research aimed to study traits of induced atrial fibrillation in horses and how flecainide modifies those traits. A total of 16 horses were used in the experiment, out of these, 3 had persistent AF, and the remaining 13 had AF induced by pacing. Seven horses served as a control group and were treated with saline, while the other eight were given flecainide. Electrocardiograms (ECGs) were used to analyze the horse’s heart rhythm. By using a computer-assisted process, the AFR was calculated from the ECGs.

Results

  • At the onset of AF, the AFR in the horses with AF induced by pacing and treated with flecainide was 295±52 fibrillations per minute.
  • The control group (without flecainide) had an AFR of 269±36 fibrillations per minute.
  • The horses with spontaneous persistent AF (without pacing) had an AFR of 364±26 fibrillations per minute – significantly higher than the control group.
  • Flecainide decreased AFR in all cases and restored regular heartbeat rhythm (sinus rhythm) in the animals with induced AF.
  • In the control group, AFR initially increased, reaching a plateau before dropping slightly. These changes were statistically significant.

Conclusion

The study supports the idea that horses might be a suitable model for studying AF since AFR in horses with induced AF is similar to that in humans with paroxysmal AF. Flecainide was found to cause a rapid decrease in AFR in all horses, which shows that it might be useful as an antiarrhythmic compound. This experiment exemplifies a non-invasive technique for studying the effect of such compounds on AF.

Cite This Article

APA
Hesselkilde EZ, Carstensen H, Haugaard MM, Carlson J, Pehrson S, Jespersen T, Buhl R, Platonov PG. (2017). Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation. BMC Cardiovasc Disord, 17(1), 289. https://doi.org/10.1186/s12872-017-0720-1

Publication

BMC cardiovascular disorders
ISSN: 1471-2261
NlmUniqueID: 100968539
Country: England
Language: English
Volume: 17
Issue: 1
Pages: 289

Researcher Affiliations

Hesselkilde, Eva Z
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Carstensen, Helena
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Haugaard, Maria M
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark.
Carlson, Jonas
  • Department of Cardiology, Lund University, 21185, Lund, Sweden.
Pehrson, Steen
  • Department of Cardiology, The Heart Centre, University of Copenhagen, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Jespersen, Thomas
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 2200, Copenhagen, Denmark.
Buhl, Rikke
  • Department of Veterinary Clinical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Højbakkegaard Allé 5, 2630, Taastrup, Denmark. rib@sund.ku.dk.
Platonov, Pyotr G
  • Arrhythmia Clinic, Skåne University Hospital and Department of Cardiology, Clinical Sciences, Lund University, 21185, Lund, Sweden.

MeSH Terms

  • Action Potentials / drug effects
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / physiopathology
  • Atrial Fibrillation / prevention & control
  • Cardiac Pacing, Artificial
  • Disease Models, Animal
  • Electrocardiography
  • Female
  • Flecainide / pharmacology
  • Heart Atria / drug effects
  • Heart Atria / physiopathology
  • Heart Rate / drug effects
  • Horses
  • Male
  • Time Factors

Grant Funding

  • DFF-1331-00313B / The Danish Council for Independent Research
  • #20140734 / The Danish Horse Levy Foundation
  • #20110875 / The Swedish Heart-Lung Foundation

Conflict of Interest Statement

ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The studies were approved by The Danish Animal Experiments Inspectorate (license number 2012–15–2934-00198) and by the local ethical committee at University of Copenhagen. The horses induced with AF were retired trotters purchased as experimental animals whereas the horses with spontaneous AF was horses presented in the clinic at The University Hospital for Large Animals, Department of Veterinary Clinical Sciences, University of Copenhagen, due to AF. Owner consent was obtained for all horses participated in the study. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

This article includes 20 references
  1. Holm M, Pehrson S, Ingemansson M, Sornmo L, Johansson R, Sandhall L, Sunemark M, Smideberg B, Olsson C, Olsson SB. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method.. Cardiovasc Res 1998;38(1):69–81.
    doi: 10.1016/S0008-6363(97)00289-7pubmed: 9683908google scholar: lookup
  2. Bollmann A, Kanuru NK, McTeague KK, Walter PF, DeLurgio DB, Langberg JJ. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide.. Am J Cardiol 1998;81(12):1439–1445.
    doi: 10.1016/S0002-9149(98)00210-0pubmed: 9645894google scholar: lookup
  3. Haugaard MM, Pehrson S, Carstensen H, Flethoj M, Hesselkilde EZ, Praestegaard KF, Diness JG, Grunnet M, Jespersen T, Buhl R. Antiarrhythmic and electrophysiologic effects of flecainide on acutely induced atrial fibrillation in healthy horses.. J Vet Intern Med 2015;29(1):339–347.
    doi: 10.1111/jvim.12496pmc: PMC4858114pubmed: 25328012google scholar: lookup
  4. Haugaard MM, Hesselkilde EZ, Pehrson S, Carstensen H, Flethoj M, Praestegaard KF, Sorensen US, Diness JG, Grunnet M, Buhl R. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.. Heart Rhythm 2015;12(4):825–835.
    doi: 10.1016/j.hrthm.2014.12.028pubmed: 25542425google scholar: lookup
  5. Else RW, Holmes JR. Pathological changes in atrial fibrillation in the horse.. Equine Vet J 1971;3(1):56–64.
    doi: 10.1111/j.2042-3306.1971.tb04441.xpubmed: 5161359google scholar: lookup
  6. Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European registry in atrial fibrillation (PREFER in AF). Europace 2014;16(1):6–14.
    doi: 10.1093/europace/eut263pmc: PMC3864758pubmed: 24084680google scholar: lookup
  7. Ohmura H, Nukada T, Mizuno Y, Yamaya Y, Nakayama T, Amada A. Safe and efficacious dosage of flecainide acetate for treating equine atrial fibrillation.. J Vet Med Sci 2000;62(7):711–715.
    doi: 10.1292/jvms.62.711pubmed: 10945288google scholar: lookup
  8. van Loon G, Blissitt KJ, Keen JA, Young LE. Use of intravenous flecainide in horses with naturally-occurring atrial fibrillation.. Equine Vet J 2004;36(7):609–614.
    doi: 10.2746/0425164044864516pubmed: 15581326google scholar: lookup
  9. De Clercq D, van Loon G, Tavernier R, Duchateau L, Deprez P. Atrial and ventricular electrical and contractile remodeling and reverse remodeling owing to short-term pacing-induced atrial fibrillation in horses.. J Vet Intern Med 2008;22(6):1353–1359.
    doi: 10.1111/j.1939-1676.2008.0202.xpubmed: 19000247google scholar: lookup
  10. Stridh M, Sornmo L. Spatiotemporal QRST. Cancellation techniques for analysis of atrial fibrillation.. IEEE Trans Biomed Eng 2001;48(1):105–111.
    doi: 10.1109/10.900266pubmed: 11235581google scholar: lookup
  11. Platonov PG, Stridh M, de Melis M, Urban L, Carlson J, Corbucci G, Holmqvist F. Analysis of atrial fibrillatory rate during spontaneous episodes of atrial fibrillation in humans using implantable loop recorder electrocardiogram.. J Electrocardiol 2012;45(6):723–726.
    doi: 10.1016/j.jelectrocard.2012.05.003pubmed: 22698889google scholar: lookup
  12. Choudhary MB, Holmqvist F, Carlson J, Nilsson HJ, Roijer A, Platonov PG. Low atrial fibrillatory rate is associated with spontaneous conversion of recent-onset atrial fibrillation.. Europace 2013;15(10):1445–1452.
    doi: 10.1093/europace/eut057pubmed: 23515337google scholar: lookup
  13. Husser D, Cannom DS, Bhandari AK, Stridh M, Sornmo L, Olsson SB, Bollmann A. Electrocardiographic characteristics of fibrillatory waves in new-onset atrial fibrillation.. Europace 2007;9(8):638–642.
    doi: 10.1093/europace/eum074pubmed: 17470676google scholar: lookup
  14. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.. Circulation 1995;92(7):1954–1968.
    doi: 10.1161/01.CIR.92.7.1954pubmed: 7671380google scholar: lookup
  15. Bollmann A, Sonne K, Esperer HD, Toepffer I, Langberg JJ, Klein HU. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG.. Cardiovasc Res 1999;44(1):60–66.
    doi: 10.1016/S0008-6363(99)00156-Xpubmed: 10615390google scholar: lookup
  16. Petrutiu S, Sahakian AV, Swiryn S. Short-term dynamics in fibrillatory wave characteristics at the onset of paroxysmal atrial fibrillation in humans.. J Electrocardiol 2007;40(2):155–160.
    doi: 10.1016/j.jelectrocard.2006.10.003pubmed: 17349458google scholar: lookup
  17. Fujiki A, Sakabe M, Nishida K, Mizumaki K, Inoue H. Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation.. Circ J 2003;67(5):391–395.
    doi: 10.1253/circj.67.391pubmed: 12736475google scholar: lookup
  18. Biffi M, Boriani G, Bronzetti G, Capucci A, Branzi A, Magnani B. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.. Heart 1999;82(2):176–182.
    doi: 10.1136/hrt.82.2.176pmc: PMC1729125pubmed: 10409531google scholar: lookup
  19. Bollmann A, Binias KH, Toepffer I, Molling J, Geller C, Klein HU. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.. Am J Cardiol 2002;90(9):1011–1014.
    doi: 10.1016/S0002-9149(02)02690-5pubmed: 12398975google scholar: lookup
  20. Platonov PG, Corino VD, Seifert M, Holmqvist F, Sornmo L. Atrial fibrillatory rate in the clinical context: natural course and prediction of intervention outcome.. Europace 2014;16(Suppl 4) iv110-iv119.
    pubmed: 25362161

Citations

This article has been cited 10 times.
  1. Wu Q, Wu X, Feng T, Chen F, Ren J, Gao S, Wang B, Li Y, Gong L. Animal and cellular models of atrial fibrillation: a review. Front Cardiovasc Med 2025;12:1617652.
    doi: 10.3389/fcvm.2025.1617652pubmed: 40860356google scholar: lookup
  2. Huang YH, Alexeenko V, Tse G, Huang CL, Marr CM, Jeevaratnam K. ECG Restitution Analysis and Machine Learning to Detect Paroxysmal Atrial Fibrillation: Insight from the Equine Athlete as a Model for Human Athletes. Function (Oxf) 2021;2(1):zqaa031.
    doi: 10.1093/function/zqaa031pubmed: 35330977google scholar: lookup
  3. Kjeldsen ST, Nissen SD, Buhl R, Hopster-Iversen C. Paroxysmal Atrial Fibrillation in Horses: Pathophysiology, Diagnostics and Clinical Aspects. Animals (Basel) 2022 Mar 10;12(6).
    doi: 10.3390/ani12060698pubmed: 35327097google scholar: lookup
  4. Buhl R, Hesselkilde EM, Carstensen H, Hopster-Iversen C, van Loon G, Decloedt A, Van Steenkiste G, Marr CM, Reef VB, Schwarzwald CC, Mitchell KJ, Nostell K, Nogradi N, Nielsen SS, Carlson J, Platonov PG. Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion. Equine Vet J 2022 Nov;54(6):1013-1022.
    doi: 10.1111/evj.13551pubmed: 34957586google scholar: lookup
  5. Saljic A, Friederike Fenner M, Winters J, Flethøj M, Eggert Eggertsen C, Carstensen H, Dalgas Nissen S, Melis Hesselkilde E, van Hunnik A, Schotten U, Sørensen U, Jespersen T, Verheule S, Buhl R. Increased fibroblast accumulation in the equine heart following persistent atrial fibrillation. Int J Cardiol Heart Vasc 2021 Aug;35:100842.
    doi: 10.1016/j.ijcha.2021.100842pubmed: 34355058google scholar: lookup
  6. Nath LC, Elliott AD, Weir J, Curl P, Rosanowski SM, Franklin S. Incidence, recurrence, and outcome of postrace atrial fibrillation in Thoroughbred horses. J Vet Intern Med 2021 Mar;35(2):1111-1120.
    doi: 10.1111/jvim.16063pubmed: 33604980google scholar: lookup
  7. Fenner MF, Carstensen H, Dalgas Nissen S, Melis Hesselkilde E, Scott Lunddahl C, Adler Hess Jensen M, Loft-Andersen AV, Sattler SM, Platonov P, El-Haou S, Jackson C, Tang R, Kirby R, Ford J, Schotten U, Milnes J, Svane Sørensen U, Jespersen T, Buhl R. Effect of selective I(K,ACh) inhibition by XAF-1407 in an equine model of tachypacing-induced persistent atrial fibrillation. Br J Pharmacol 2020 Aug;177(16):3778-3794.
    doi: 10.1111/bph.15100pubmed: 32436234google scholar: lookup
  8. Hesselkilde EZ, Carstensen H, Flethøj M, Fenner M, Kruse DD, Sattler SM, Tfelt-Hansen J, Pehrson S, Braunstein TH, Carlson J, Platonov PG, Jespersen T, Buhl R. Longitudinal study of electrical, functional and structural remodelling in an equine model of atrial fibrillation. BMC Cardiovasc Disord 2019 Oct 21;19(1):228.
    doi: 10.1186/s12872-019-1210-4pubmed: 31638896google scholar: lookup
  9. Carstensen H, Hesselkilde EZ, Haugaard MM, Flethøj M, Carlson J, Pehrson S, Jespersen T, Platonov PG, Buhl R. Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation. J Cardiovasc Electrophysiol 2019 Apr;30(4):596-606.
    doi: 10.1111/jce.13849pubmed: 30661267google scholar: lookup
  10. Carstensen H, Hesselkilde EZ, Fenner M, Loft-Andersen AV, Flethøj M, Kanters JK, Sattler SM, Tfelt-Hansen J, Pehrson S, Jespersen T, Buhl R. Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses. J Vet Intern Med 2018 Sep;32(5):1708-1717.
    doi: 10.1111/jvim.15287pubmed: 30133839google scholar: lookup
Subscribe to our newsletter
Join 99,417 horse owners like you who receive our email updates on horse health and nutrition.